|Day's Range||31.97 - 32.28|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||27.32|
|Dividend & Yield||1.28 (3.99%)|
|1y Target Est||N/A|
Combined sales for Januvia and Janumet were ~$1.3 billion for 1Q17, a ~5.0% fall from $1.4 billion in 1Q16.
Puma Biotechnology Inc (NASDAQ: PBYI ) popped 88 percent Monday on news that its neratinib candidate , an early-stage breast cancer treatment for human epidermal growth factor receptor-2 (HER2) positive ...
Merck & Co may face financial penalties from U.K. regulators after the Competition & Markets Authority released provisional findings of a drug pricing investigation into the American drugmaker.